#InternationalYogaDay, we embrace yoga as a powerful tool for holistic healing 🌿 Gentle practice helps manage cancer treatment side effects, lower stress & restore strength.
🌐 https://t.co/UdOLsqPvk7
📞 9372766965 https://t.co/Mxoqf9KjmE
#InternationalYogaDay, we embrace yoga as a powerful tool for holistic healing 🌿 Gentle practice helps manage cancer treatment side effects, lower stress & restore strength. Wishing you peace on your wellness journey.
🌐 https://t.co/UdOLsqPvk7
📞 9372766965
#YogaDay#CancerCare
Our nurses are the frontline of hope. Today, we honor their immense strength, clinical skill, and the daily sacrifices they make to provide exceptional, barrier-free cancer care to every patient. Happy Nurses Day!
🌐 https://t.co/UdOLsqPvk7
📞 9372766965
#InternationalNursesDay
Honoring the incredible Strength and Resilience of #Mothers Everywhere. Your love is a powerful beacon, especially for families facing health challenges.
#PCCCancerCare stands with you, committed to providing barrier-free support. 🤍
Visit https://t.co/UdOLsqPvk7
Call 9372766965
Exciting progress in the fight against cancer! 🧬 Q1 2026 saw major FDA approvals, AI-driven diagnostics, and a strong reminder that 37% of global cases are linked to preventable lifestyle factors.
🌐 https://t.co/UdOLsqPvk7
📞 9372766965
#OncologyUpdates#PCCCancerCare
Decoding Mismatch Repair (MMR) testing by IHC is crucial for precise cancer diagnostics and assessing Lynch Syndrome risk. 🧬
⭐ Key takeaway: Always interpret MMR as pairs, not individual markers!
🌐 https://t.co/UdOLsqPvk7
📞 9372766965
#PrecisionOncology#LynchSyndrome#PCC
New research update: Could GLP-1 agonists revolutionize colon cancer survival? 🧬
~58% relative reduction in 5-year mortality among users vs. non-users.
Cancer Care without Barriers. 🩺
📞 9372766965
🌐 https://t.co/UdOLsqPvk7
#Oncology#ColonCancer#MedicalResearch#PCC#GLP1
At PCC, we believe true prosperity starts with health. With ~40% of cancer cases being preventable, the best investment you can make today is in early detection and wellness.
Cancer Care without Barriers. 🩺
📞 9372766965
🌐 https://t.co/UdOLsqPvk7
#AkshayTritiya#PCC
The universe is a predictive math engine. And we are the part of that engine that became curious enough to ask what it is made of.
That question, and the fact that the mathematics answers back with such crystalline precision, is the most extraordinary fact in all of existence.
We — conscious, questioning beings — are substructures of this mathematical system that have become complex enough to discover the mathematical structure they are made of.
🚫 80% OF HEAD AND NECK CANCERS ARE PREVENTABLE.
Lifestyle changes are powerful. Controllable risk factors include:
🚬 Tobacco use
🍷 Heavy alcohol consumption
🦠 Persistent HPV infection
Prevention is a proactive choice. #HNSCC#PCC
🌐 https://t.co/UdOLsqPvk7
📞 9372766965
Immunotherapy is a powerful tool against cancer, but proactive monitoring is key. 🔬
While immune-related adverse events (irAEs) can occur, up to 90% of severe side effects are preventable with early detection and expert care.
📞 9372766965
🌐 https://t.co/UdOLsqPvk7
Lymphoma isn't just one disease—there are 60+ distinct types, each needing a unique, personalized treatment plan.
At PCC Cancer Care, we combine advanced research with targeted medicine to fight cancers of the immune system
📞 9372766965
🌐 https://t.co/UdOLsqPvk7
#PCCCancerCare
PFS endpoints met in the Phase 3 DUO-O trial! The combination of first-line durvalumab + chemo + bevacizumab, followed by maintenance (D+B+O), shows statistical significance in non-tBRCAm HRD+ and ITT ovarian cancer populations. 🧬🔬
🌐 https://t.co/UdOLsqPvk7
📞 9372766965
New FDA approval: A nivolumab + AVD chemo regimen is now a first-line option for Stage III/IV classical Hodgkin lymphoma! 🎗️
With a 94% 1-year progression-free survival rate in trials, this is a major win for patients 12+.
🌐 https://t.co/UdOLsqPvk7
📞 9372766965
#Lymphoma#PCC
The landscape of #ProstateCancer treatment is shifting toward total personalization. 🧬 From localized surveillance to advanced #targetedtherapies like PARP inhibitors and PSMA-directed care, our latest algorithm maps the journey #PCC
🌐 https://t.co/UdOLsqPvk7
📞 9372766965
Major step forward in #LungCancer care🔬 The FDA has expanded approval for Hernexeos, making it a first-line targeted treatment for #HER2-mutant #NSCLC. With a 76% response rate in new patients, early biomarker testing is imperative! #PCC
🌐 https://t.co/UdOLsqPvk7
📞 9372766965
Top 3 Colon Cancer FAQs: Screen from age 45, watch for bowel changes, and stay active to lower risk. Expert care at PCC.
https://t.co/UdOLsqPvk7 | 9372766965